Analyst Recommendations

BMO Capital analyst issues OUTPERFORM recommendation for WK on February 21, 2024 12:00PM ET. The previous analyst recommendation was Outperform.WK was trading at $80.75 at issue of the...

February 21, 2024   WK 4.19%

RBC Capital analyst issues BUY recommendation for IDYA on February 21, 2024 11:01AM ET. The previous analyst recommendation was Buy.IDYA was trading at $44.24 at issue of the...

February 21, 2024   IDYA 0.77%

Small Cap Consumer Research analyst issues OUTPERFORM recommendation for SSEUF on February 21, 2024 12:28PM ET. The previous analyst recommendation was Outperform.SSEUF was trading at $0 at issue...

February 21, 2024   SSEUF -0.28%

RBC Capital analyst issues OUTPERFORM recommendation for TDOC on February 21, 2024 12:44PM ET. The previous analyst recommendation was Outperform.TDOC was trading at $15.2801 at issue of the...

February 21, 2024   TDOC 15.48%

William Blair analyst issues OUTPERFORM recommendation for NGS on February 21, 2024 11:01AM ET. The previous analyst recommendation was Outperform.NGS was trading at $15.825 at issue of the...

February 21, 2024   NGS -0.43%

RBC Capital analyst issues BUY recommendation for IDYA on February 21, 2024 11:01AM ET. The previous analyst recommendation was Buy.IDYA was trading at $44.24 at issue of the...

February 21, 2024   IDYA 0.77%

Jefferies analyst issues OUTPERFORM recommendation for CHH on February 21, 2024 11:01AM ET. The previous analyst recommendation was Outperform.CHH was trading at $113.47 at issue of the analyst...

February 21, 2024   CHH 0.68%

Barclays analyst issues UNDERPERFORM recommendation for CHH on February 21, 2024 11:01AM ET. The previous analyst recommendation was Underperform.CHH was trading at $113.47 at issue of the analyst...

February 21, 2024   CHH 0.68%

Wells Fargo analyst issues OVERWEIGHT recommendation for SOUN on February 21, 2024 10:07AM ET. The previous analyst recommendation was Overweight.SOUN was trading at $3.72 at issue of the...

February 21, 2024   SOUN 5.93%

Truist Financial analyst issues BUY recommendation for GMED on February 21, 2024 09:00AM ET. The previous analyst recommendation was Buy.GMED was trading at $56.47 at issue of the...

February 21, 2024   GMED 0.15%